Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$17.13 - $38.52 $2.94 Million - $6.6 Million
-171,400 Reduced 42.78%
229,275 $5.22 Million
Q4 2022

Feb 13, 2023

SELL
$29.44 - $37.31 $5.02 Million - $6.36 Million
-170,503 Reduced 29.85%
400,675 $13.7 Million
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $608,293 - $820,900
-21,092 Reduced 3.56%
571,178 $17.4 Million
Q2 2022

Aug 15, 2022

BUY
$33.25 - $45.11 $24,605 - $33,381
740 Added 0.13%
592,270 $22.1 Million
Q1 2022

May 16, 2022

SELL
$40.68 - $49.72 $1.36 Million - $1.66 Million
-33,400 Reduced 5.34%
591,530 $26.8 Million
Q4 2021

Feb 11, 2022

SELL
$43.21 - $57.6 $1.82 Million - $2.43 Million
-42,167 Reduced 6.32%
624,930 $30.1 Million
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $116,160 - $132,704
-2,200 Reduced 0.33%
667,097 $37.1 Million
Q2 2021

Aug 16, 2021

SELL
$51.29 - $59.15 $1.99 Million - $2.29 Million
-38,792 Reduced 5.48%
669,297 $36.3 Million
Q1 2021

May 17, 2021

SELL
$42.18 - $56.07 $376,498 - $500,480
-8,926 Reduced 1.24%
708,089 $39.7 Million
Q4 2020

Feb 12, 2021

SELL
$35.18 - $43.52 $97,061 - $120,071
-2,759 Reduced 0.38%
717,015 $31.2 Million
Q3 2020

Nov 16, 2020

SELL
$37.98 - $48.72 $387,395 - $496,944
-10,200 Reduced 1.4%
719,774 $28 Million
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $363,394 - $523,279
11,696 Added 1.63%
729,974 $31.6 Million
Q1 2020

May 14, 2020

BUY
$22.46 - $42.24 $1.14 Million - $2.14 Million
50,601 Added 7.58%
718,278 $23.9 Million
Q4 2019

Feb 11, 2020

BUY
$39.01 - $47.51 $26 Million - $31.7 Million
667,677 New
667,677 $27.7 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.